Literature DB >> 2611218

Solution structure of the parallel-stranded duplex oligonucleotide alpha-d(TCTAAAC)-beta-d(AGATTTG) via complete relaxation matrix analysis of the NOE effects and molecular mechanics calculations.

G Lancelot1, J L Guesnet, F Vovelle.   

Abstract

The solution structure of the duplex formed by the association of the unnatural oligonucleotide alpha-d(TCTAAAC) with its natural and parallel complementary sequence beta-d(AGATTTG) was investigated by nuclear magnetic resonance spectroscopy and constrained molecular mechanics calculations. The structure was refined on the basis of interproton distances determined by NOE measurements for a series of mixing times. The NOE values were converted to distances by using the complete 134 x 134 relaxation matrix including all proton dipole-dipole interactions and spin diffusion. The computation of the relaxation matrix requires the Cartesian coordinates of the oligonucleotide, which are not known, a priori. To avoid this ambiguity, we used an iterative procedure in which the new distance constraints are obtained by using the complete relaxation matrix calculated from the previous structure. After three iterations, the process converged. The unnatural duplex alpha-d(TCTAAAC)-beta-d(AGATTTG) adopts in solution a right-helical structure with Watson-Crick base pairing, an anti conformation on the glycosyl linkage on the beta-strand, a syn conformation on the alpha-strand, and a 3'-exo conformation of the deoxyriboses for both sugar anomers. The three-dimensional structure obtained allowed us to describe the local heterogeneity of the duplex.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2611218     DOI: 10.1021/bi00445a049

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  NMR structure of a parallel-stranded DNA duplex at atomic resolution.

Authors:  V Rani Parvathy; Sukesh R Bhaumik; Kandala V R Chary; Girjesh Govil; Keliang Liu; Frank B Howard; H Todd Miles
Journal:  Nucleic Acids Res       Date:  2002-04-01       Impact factor: 16.971

2.  Solution structure of oligonucleotides covalently linked to a psoralen derivative.

Authors:  O Bornet; C Prévost; F Vovelle; M Chassignol; N T Thuong; G Lancelot
Journal:  Nucleic Acids Res       Date:  1995-03-11       Impact factor: 16.971

3.  Structure and conformation in solution of the parallel-stranded hybrid alpha-d(CGCAATTCGC).beta-d(GCGTTAAGCG) by high-resolution 2D NMR.

Authors:  W H Gmeiner; B Rayner; F Morvan; J L Imbach; J W Lown
Journal:  J Biomol NMR       Date:  1992-05       Impact factor: 2.835

4.  The solution structure of a 3'-phenazinium (Pzn) tethered DNA-RNA duplex with a dangling adenosine: r(5'G-AUUGAA3'):d(5'TCAATC3'-Pzn).

Authors:  T V Maltseva; P Agback; M N Repkova; A G Venyaminova; E M Ivanova; A Sandström; V F Zarytova; J Chattopadhyaya
Journal:  Nucleic Acids Res       Date:  1994-12-25       Impact factor: 16.971

5.  Sequence-specific interaction of alpha-beta-anomeric double-stranded DNA with the p50 subunit of NF kappa B: application to the decoy approach.

Authors:  H Tanaka; P Vickart; J R Bertrand; B Rayner; F Morvan; J L Imbach; D Paulin; C Malvy
Journal:  Nucleic Acids Res       Date:  1994-08-11       Impact factor: 16.971

6.  Difference in conformational diversity between nucleic acids with a six-membered 'sugar' unit and natural 'furanose' nucleic acids.

Authors:  Eveline Lescrinier; Matheus Froeyen; Piet Herdewijn
Journal:  Nucleic Acids Res       Date:  2003-06-15       Impact factor: 16.971

7.  On the prebiotic selection of nucleotide anomers: A computational study.

Authors:  Lázaro A M Castanedo; Chérif F Matta
Journal:  Heliyon       Date:  2022-06-09

8.  Anomeric DNA Strand Displacement with α-D Oligonucleotides as Invaders and Ethidium Bromide as Fluorescence Sensor for Duplexes with α/β-, β/β- and α/α-D Configuration.

Authors:  Aigui Zhang; Dasharath Kondhare; Peter Leonard; Frank Seela
Journal:  Chemistry       Date:  2022-07-04       Impact factor: 5.020

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.